South Korea MFDS registration In Vitro Formulation No. 23-39

High-risk infection immunoassay reagent

KO: 고위험성감염체면역검사시약
South Korea flagSouth Korea·Class III·Abbott Korea Diagnostics·Approved Jan 18, 2023
Basic information
Item Serial Number
2023000323
License Number
In Vitro Formulation No. 23-39
체외제허23-39호
Classification Number
K05030.01(3)
Device Class (Risk Classification)
Class III
Classification Name
High-risk infection immunoassay reagent
고위험성감염체면역검사시약
Official English Name
IVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method
Company information
Entity Name (Company)
Abbott Korea Diagnostics
(주)한국애보트진단
Entity Address
경기도 용인시 기흥구 하갈로15번길 46 (보라동)
Category
Manufacturing
제조업
Business License Number
체외 제 4452 호
Important dates & status
Item Approval Date
Jan 18, 2023
Business Permit Date
Feb 05, 2014
Expiration Period
2023-01-18 ~ 2028-01-17
For Export
아니오
Model information
Model Name
41FK16 and 1 other case
41FK16외 1건
About this record

This Class III medical device is registered with South Korea's Ministry of Food and Drug Safety (MFDS / 식품의약품안전처) under license number In Vitro Formulation No. 23-39. Approved on Jan 18, 2023. Registered by Abbott Korea Diagnostics.

Pure Global AI provides free access to comprehensive South Korea MFDS registration data, helping global MedTech companies analyze market presence and regulatory compliance for medical devices in South Korea.

Free DatabasePowered by Pure Global AIMFDS Official DataClass III